Perbedaan Capaian Kontrasepsi Pascasalin Jangka Panjang Sebelum dan Saat Pandemi Covid-19

Dave Orlando Gumay,(1*) Dini Pusianawati,(2) Hartanto Bayuaji,(3)

(1) Departemen Obstetri & Ginekologi Fakultas Kedokteran Univesitas Padjajaran/ RSUP Dr. Hasan Sadikin Bandung
(2) Departemen Obstetri & Ginekologi Fakultas Kedokteran Univesitas Padjajaran/ RSUP Dr. Hasan Sadikin Bandung
(3) Departemen Obstetri & Ginekologi Fakultas Kedokteran Univesitas Padjajaran/ RSUP Dr. Hasan Sadikin Bandung
(*) Corresponding Author

Abstract


Tujuan: Mengetahui perbedaan capaian kontrasepsi pascasalin jangka panjang sebelum dan saat pandemi COVID-19 di RSUP dr. Hasan Sadikin Bandung.
Metode: Penelitian ini adalah studi analitik observasional dengan pendekatan potong silang menggunakan data sekunder dari rekam medik subjek penelitian selama masa pengamatan yakni sebelum pandemi (1 Maret 2019–28 Februari 2020) dan saat pandemi (1 Maret 2020–28 Februari 2021). Dilakukan analisis perbedaan capaian kontrasepsi pascasalin jangka panjang sebelum dan saat pandemi COVID-19, serta perbedaan capaian penggunaan kontrasepsi pascasalin jangka panjang berdasarkan status infeksi COVID-19 menggunakan uji chi-square. Nilai P <0,05 dianggap bermakna secara statistik.
Hasil: Selama periode pengamatan didapatkan proporsi subjek yang mendapatkan layanan kontrasepsi pascasalin pada periode pandemi lebih tinggi secara bermakna dibandingkan dengan kelompok sebelum pandemi (38,8% vs 27,7%, P<0,001). Tidak didapatkan perbedaan bermakna sebaran penggunaan metode kontrasepsi pada kelompok saat pandemi yang terinfeksi dan tidak terinfeksi COVID-19.
Kesimpulan: Capaian pemberian kontrasepsi pascasalin jangka panjang saat pandemi lebih tinggi secara bermakna dibandingkan dengan sebelum pandemi. Tidak didapatkan perbedaan yang bermakna capaian kontrasepsi pascasalin jangka panjang saat pandemi pada subjek yang terinfeksi dan tidak terinfeksi COVID-19.

Differences in Long-Term Postpartum Contraception Achievements Before and During The Covid-19 Pandemic

Abstract
Objective: To find out the difference in the achievement of long-term postpartum contraception before and during the COVID-19 pandemic at dr. Hasan Sadikin Bandung.
Methods: This research is an observational analytic study with a cross-sectional approach using secondary data from the medical records of the research subjects during the observation period before the pandemic (1 March 2019–28 February 2020) and during the pandemic (1 March 2020–28 February 2021). An analysis of the difference in the achievement of long-term postpartum contraception before and during the COVID-19 also differences in achievement of long-term postpartum contraceptive use was carried out based on the status of COVID-19 infection was conducted using the chi-square test. P-value < 0.05 was considered statistically significant.
Results: During the observation period, there were the proportion of subjects who received postpartum contraceptive services during the pandemic period was significantly higher than the group before the pandemic (38.8% vs 27.7%, P<0.001). Postpartum contraceptive use in the group during the pandemic infected with COVID-19 was lower than in the uninfected subjects (32.4% vs. 39.4%, P=0.07). There was no significant difference in the distribution of contraceptive methods used in the infected and uninfected groups during the COVID-19 pandemic.
Conclusion: The achievement of long-term postpartum contraception during the pandemic was significantly higher than before the pandemic. There was no significant difference in the achievement of long-term postpartum contraception during the pandemic in subjects who were infected and not infected with COVID-19.

Key words: COVID-19, postpartum contraception, pandemic.


Keywords


COVID-19, kontrasepsi pascasalin, pandemi

Full Text:

PDF

References


Dev R, Kohler P, Feder M, Unger J, Woods N, Drake A. A systematic review and meta-analysis of postpartum contraceptive use among women in low- and middle-income countries. Reprod Health. 2019;16(1):154.

Sonalkar S, Gaffield M. Introducing the world health organization postpartum family planning compendium. Int J Gynaecol Obstet. 2017;136(1):2-5.

Oduyebo T, Zapata L, Boutot M, Tepper N, Curtis K, D'Angelo D, et al. Factors associated with postpartum use of long-acting reversible contraception. American journal of obstetrics and gynecology. 2019;221(1):43.e1-.e11.

ACOG. Interpregnancy care. ACOG. 2019;133:51-3.

Cooper M. Postpartum contraception2018 09 Juli 2018. 159-66 p.

Hutcheon J, Nelson H, Stidd R, Moskosky S, Ahrens K. Short interpregnancy intervals and adverse maternal outcomes in high-resource settings: An updated systematic review. Paediatric and perinatal epidemiology. 2019;33(1):O48-o59.

Schummers L, Hutcheon J, Hernandez D, Williams P, Hacker M, Vander T, et al. Association of short interpregnancy interval with pregnancy outcomes according to maternal age. JAMA Intern Med. 2018;178(12):1661-70.

Kementerian Kesehatan RI. Profil kesehatan Indonesia tahun 2019. 2020.

Ferreira E, de Melo N, Sorpreso I, Bahamondes L, Simões R, Soares-J, et al. Contraception and reproductive planning during the COVID-19 pandemic. Expert Rev Clin Pharmacol. 2020;13(6):615-22.

Impact of COVID-19 on family planning: what we know one year into the pandemic [Internet]. UNFPA. 2021 [cited 1 Juni 2021]. Available from: https://www.unfpa.org/resources/impact-covid-19-family-planning-what-we-know-one-year-pandemic.

Mickler A, Carrasco M, Raney L, Sharma V, May A, Greaney J. Applications of the high impact practices in family planning during COVID-19. SRHM. 2021;29(1):1881210.

Eka G. The role of long-term contraceptive services in the COVID-19 pandemic era. Indones J Obstet Gynecol. 2021;9(2):63.

Kementerian Kesehatan Indonesia. Panduan pelayanan keluarga berencana dan kesehatan reproduksi dalam situasi pandemi COVID-192020 1 Juni 2021. [cited 2021:[2 p.]. Available from: https://infeksiemerging.kemkes.go.id/download/Panduan_Pelayanan_KB_dan_Kespro_Dalam_Situasi_Pandemi_COVID-19.pdf.

Sharma K, Zangmo R, Kumari A, Roy K, Bharti J. Family planning and abortion services in COVID-19 pandemic. Taiwan J Obstet Gynecol. 2020;59(6):808-11.

Sakowicz A, Matovina C, Imeroni S, Daiter M, Barry O, Grobman WA, et al. 591 The association between COVID-19 related health services changes and postpartum contraception. Am J Obstet Gynecol. 2021;224(2):S372-S.

Miller HE, Henkel A, Leonard SA, Miller SE, Tran L, Bianco K, et al. The impact of the COVID-19 pandemic on postpartum contraception planning. Am J Obstet Gynecol MFM. 2021;3(5):100412-.

United Nations Population Fund. Impact of COVID-19 on access to contraceptives in the LAC region [Internet]. UNPFA. [cited 15 September 2020]. Available from: https://lac.unfpa.org/sites/default/files/pub-pdf/technical_report_impact_of_covid_19_in_the_access_to_contraceptives_in_lac_1_2.pdf.

Riley T, Sully E, Ahmed Z, Biddlecom A. Estimates of the potential impact of the COVID-19 pandemic on sexual and reproductive health in low- and middle-income countries. International perspectives on sexual and reproductive health. 2020;46:73-6.

Gupta P, Kumar S, Sharma SS. SARS-CoV-2 prevalence and maternal-perinatal outcomes among pregnant women admitted for delivery: Experience from COVID-19-dedicated maternity hospital in Jammu, Jammu and Kashmir (India). Journal of medical virology. 2021;93(9):5505-14.

Campbell KH, Tornatore JM, Lawrence KE, Illuzzi JL, Sussman LS, Lipkind HS, et al. Prevalence of SARS-CoV-2 among patients admitted for childbirth in Southern Connecticut. JAMA. 2020;323(24):2520-2.

Kementerian Kesehatan Indonesia. Peta sebaran COVID-19 Jakarta: Kementerian Kesehatan Indonesia.; [cited 2021 15 September 2021]. Available from: https://covid19.go.id/peta-sebaran-covid19.

Kementerian Perencanaan Pembangunan Nasional. Modul sinkronisasi RPJMD dengan RPJMN bidang kesehatan dan gizi masyarakat. 2017:13.




DOI: http://dx.doi.org/10.24198/obgynia/v5n2.393

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


     
       

Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat